OrthoPediatrics entered into an exclusive distribution agreement with 3D-Side, a software developer and manufacturer of patient-specific 3D-printed cutting guides. This grants OrthoPediatrics the exclusive distribution rights for the 3D-CUT-OSTEO osteotomy guide in U.S. pediatric hospitals, in addition to certain international markets in the future.
3D-CUT patient-specific guides, designed from CT or MRI images, help surgeons perform corrective and bone tumor resection osteotomies. The single-use guide technology enables accurate deformity or tumor corrective procedures.
OrthoPediatrics’ President and CEO David Bailey said, “3D-Side technology complements the OrthoPediatrics’ pediatric limb deformity implant and biologic offering, and increases exposure in the pediatric oncology market, where many of the most challenging orthopedic cases involving tumor resection require a full complement of solutions including implants, biologics and patient specific devices.”
3D-Side Co-CEO, Laurent Paul said, “Because each patient is unique, we imagine dedicated solutions to fit their surgical needs. Thanks to the OrthoPediatrics partnership, we are thrilled to expand these well-established products in Europe to the USA and bring our expertise to pediatric orthopedic surgeons in the United States.”
OrthoPediatrics entered into an exclusive distribution agreement with 3D-Side, a software developer and manufacturer of patient-specific 3D-printed cutting guides. This grants OrthoPediatrics the exclusive distribution rights for the 3D-CUT-OSTEO osteotomy guide in U.S. pediatric hospitals, in addition to certain international markets in the...
OrthoPediatrics entered into an exclusive distribution agreement with 3D-Side, a software developer and manufacturer of patient-specific 3D-printed cutting guides. This grants OrthoPediatrics the exclusive distribution rights for the 3D-CUT-OSTEO osteotomy guide in U.S. pediatric hospitals, in addition to certain international markets in the future.
3D-CUT patient-specific guides, designed from CT or MRI images, help surgeons perform corrective and bone tumor resection osteotomies. The single-use guide technology enables accurate deformity or tumor corrective procedures.
OrthoPediatrics’ President and CEO David Bailey said, “3D-Side technology complements the OrthoPediatrics’ pediatric limb deformity implant and biologic offering, and increases exposure in the pediatric oncology market, where many of the most challenging orthopedic cases involving tumor resection require a full complement of solutions including implants, biologics and patient specific devices.”
3D-Side Co-CEO, Laurent Paul said, “Because each patient is unique, we imagine dedicated solutions to fit their surgical needs. Thanks to the OrthoPediatrics partnership, we are thrilled to expand these well-established products in Europe to the USA and bring our expertise to pediatric orthopedic surgeons in the United States.”
Copy to clipboard 
